FDA Inspection
Roslin Cell Therapies LimitedRoslin Cell Therapies Limited – FDA Inspection, Jan 21, 2025
Record Details
This FDA Inspection record concerns Roslin Cell Therapies Limited, with an inspection on January 21, 2025, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · c4d0fa03-166c-4f41-8716-9f531c1d595c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1258906
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Roslin Cell Therapies Limited
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2023 | Not classified | Office of Inspections and Investigations |
Other documents for Roslin Cell Therapies Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.